Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapering fentanyl/midazolam vs switching to dexmedetomidine for restlessness during ventilator weaning in PICU
IRCT20211221053474N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fentanyl, midazolam and dexmedetomidine in sedative use disorder (SUD), agitation and Weaning failure (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Restlessness during ventilator weaning. Started Mar 2023; status: completed.
02
Drugs
fentanylmidazolamdexmedetomidine
03
Conditions
sedative use disorder (SUD)agitationWeaning failure
Beyond the preview
Go deeper on IRCT20211221053474N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211221053474N1.